These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19286162)

  • 1. Wnt/betacatenin signaling in adrenocortical stem/progenitor cells: implications for adrenocortical carcinoma.
    Kim A; Giordano TJ; Kuick R; Serecky K; Hammer GD
    Ann Endocrinol (Paris); 2009 Jun; 70(3):156. PubMed ID: 19286162
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.
    Penny MK; Finco I; Hammer GD
    Mol Cell Endocrinol; 2017 Apr; 445():42-54. PubMed ID: 27940298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.
    Simon DP; Hammer GD
    Mol Cell Endocrinol; 2012 Mar; 351(1):2-11. PubMed ID: 22266195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt/beta-catenin pathway in adrenocortical development and cancer.
    El Wakil A; Lalli E
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):32-7. PubMed ID: 21094679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-catenin in adrenal zonation and disease.
    Little DW; Dumontet T; LaPensee CR; Hammer GD
    Mol Cell Endocrinol; 2021 Feb; 522():111120. PubMed ID: 33338548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
    Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toying with fate: Redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue.
    Röhrig T; Pihlajoki M; Ziegler R; Cochran RS; Schrade A; Schillebeeckx M; Mitra RD; Heikinheimo M; Wilson DB
    Mol Cell Endocrinol; 2015 Jun; 408():165-77. PubMed ID: 25498963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical cytopathology.
    Sasano H; Shizawa S; Nagura H
    Am J Clin Pathol; 1995 Aug; 104(2):161-6. PubMed ID: 7639190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of beta-catenin signaling pathway on stem cell differentiation in the skin].
    Blanpain C
    Med Sci (Paris); 2007 Jan; 23(1):34-6. PubMed ID: 17212929
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiogenesis in adrenocortical physiology and tumor development.
    Feige JJ
    Ann Endocrinol (Paris); 2009 Jun; 70(3):153-5. PubMed ID: 19286163
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differentiation of adrenocortical cells and tumorigenesis of adrenocortical neoplasia].
    Sasano H; Nakamura Y
    Nihon Rinsho; 2011 Mar; 69 Suppl 2():463-8. PubMed ID: 21830584
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenocortical stem and progenitor cells: unifying model of two proposed origins.
    Wood MA; Hammer GD
    Mol Cell Endocrinol; 2011 Apr; 336(1-2):206-12. PubMed ID: 21094677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocortical tumorigenesis.
    Beuschlein F; Reincke M
    Ann N Y Acad Sci; 2006 Nov; 1088():319-34. PubMed ID: 17192577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical carcinoma in a 3% years old girl with hetro-sexual precocity.
    Shimelis D; Tadesse A; Schneider J; Tilahun B
    Ethiop Med J; 2014 Apr; 52(2):91-4. PubMed ID: 25588290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex.
    Kim AC; Reuter AL; Zubair M; Else T; Serecky K; Bingham NC; Lavery GG; Parker KL; Hammer GD
    Development; 2008 Aug; 135(15):2593-602. PubMed ID: 18599507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.